Lipum received grant from SWElife

Our project “Validation of a biological candidate drug” has been granted support from SWElife “Projects for better health” program.

The competition was fierce so the green tie was used during the interview and Lipum was then one of 22 projects granted. In total 123 applications were submitted, read more (Swedish). – This is a quality stamp for our approach and enable us to proceed faster, CEO Einar Pontén said while celebrating at the Umeå Biotech Incubator.

 

SWElife is a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners. We support collaboration within academia, industry and healthcare, with the goal to strengthen Life Science in Sweden and to improve public health.

2018-08-15T14:41:05+00:00